Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Local anesthetics produce analgesia by reversibly inhibiting voltage-gated sodium channels in neuronal membranes, thereby blocking the initiation and propagation of action potentials in peripheral nerves[1][2][4][5]. This mechanism prevents the transmission of pain and other sensory modalities from local tissue to the central nervous system, resulting in localized loss of pain sensation. Different classes of local anesthetics (amides and esters) act primarily at this molecular site, and their tissue effects can be modulated by formulations (e.g., liposomal bupivacaine) or adjuncts (e.g., vasoconstrictors) to prolong analgesia or reduce systemic toxicity[1][2][3][5].
Reversible blockade of voltage-gated sodium channels in neuronal membranes, inhibiting action potential propagation and thus preventing pain transmission[1][2][4][5]
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Voltage-gated sodium channel (site of action for local anesthetics) (VGSC (if referencing the channel class); specific subtypes (e.g., Nav1.7) may be used in primary literature, but not specified here due to lack of explicit information in the search results.).